- RecruitingPhase I
First-in-human study of RO7812653
This study is testing a new medicine, RO7812653, for early Alzheimer's disease. We want to see if it's safe, how it works in the body, and if it could help. Some people will get the medicine, others a dummy treatment (placebo), given by injection into the lower back.
For: Early symptomatic Alzheimer’s disease (eAD)United Kingdom · England · Scotland - RecruitingPHASE1
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)
This study is testing a new medication called RO7812653 for early Alzheimer's disease. Researchers want to see if it's safe, how the body handles it, and if it has any effects. They are comparing it to a dummy treatment (placebo) in people aged 50-75.
For: Alzheimer's DiseaseCanada · Netherlands · Spain